• Citer

Identification and interpretation of clinical and quality of life prognostic factors for survival and response to treatment in first-line chemotherapy in advanced breast cancer.

par Kramer, J A;Curran, D.;Piccart-Gebhart, Martine ;de Haes, J C;Bruning, Peter;Klijn, J G;Van Hoorebeeck, Irène;Paridaens, R.
Référence European journal of cancer, 36, 12, page (1498-1506)
Publication Publié, 2000-08

Article révisé par les pairs

• Détails
• Contenu

Titre:	Identification and interpretation of clinical and quality of life prognostic factors for survival and response to treatment in first-line chemotherapy in advanced breast cancer.
Auteur:	Kramer, J A; Curran, D.; Piccart-Gebhart, Martine; de Haes, J C; Bruning, Peter; Klijn, J G; Van Hoorebeeck, Irène; Paridaens, R.
Informations sur la publication:	European journal of cancer, 36, 12, page (1498-1506)
Statut de publication:	Publié, 2000-08
Sujet CREF:	Sciences bio-médicales et agricoles
MeSH keywords:	Adolescent
	Adult
	Aged
	Antineoplastic Agents -- therapeutic use
	Antineoplastic Agents, Phytogenic -- therapeutic use
	Breast Neoplasms -- drug therapy
	Breast Neoplasms -- mortality
	Doxorubicin -- therapeutic use
	Female
	Humans
	Middle Aged
	Multivariate Analysis
	Paclitaxel -- therapeutic use
	Prognosis
	Quality of Life
	Survival Analysis
	Treatment Outcome
Note générale:	Clinical Trial
	Clinical Trial, Phase II
	Clinical Trial, Phase III
	Comparative Study
	Journal Article
	Multicenter Study
	Randomized Controlled Trial
	Research Support, Non-U.S. Gov't
Langue:	Anglais
Identificateurs:	urn:issn:0959-8049
	info:pii/S0959-8049(00)00144-1
	info:pmid/10930797